India and Armenia Sign Key MoU to Enhance Medical Product Regulation
On March 11, 2025, India and Armenia strengthened their bilateral ties by signing a significant Memorandum of Understanding (MoU) aimed at enhancing cooperation in the regulation of medical products. This agreement was formalized during the visit of Armenian Foreign Minister Ararat Mirzoyan to India.
The MoU was signed between India's Central Drugs Standard ControlOrganisation (CDSCO) and Armenia's Center of Drug and Medical Technology Expertise (CDMTE), marking a crucial step towards improved regulatory frameworks for medical products in both countries. The collaboration is expected to facilitate the exchange of best practices and enhance the safety and efficacy of medical products.
During his visit, Minister Mirzoyan held discussions with Indian External Affairs Minister S. Jaishankar, focusing on various aspects of India-Armenia relations, including trade, economy, education, and cultural exchanges. Both leaders expressed optimism about expanding cooperation in digital technologies and pharmaceuticals.
The MoU reflects a commitment to deeper bilateral engagement, underscoring the historical ties and mutual interests shared by India and Armenia. As both nations explore opportunities for collaboration, this agreement is poised to have a significant impact on the pharmaceutical sectors in both countries, ensuring better access to safe medical products for their populations.
2026-10-12
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
GM Crop Area Reaches 216 Million Hectares
-
FDA Delays Beetroot Red and Spirulina Color Orders
-
GM Crop Area Reaches 216 Million Hectares
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
FDA Slams Door on Chinese Food Exports: Inspection Refusals Trigger Automatic Detentions
-
U.S. Formally Publishes India PFA Trade Cases, Raising New Barriers for Fluoropolymer Supply
-
China’s New Food-Contact Standards Take Effect, Resetting Compliance for Coatings and Silicone Rubber
-
Colombia Makes Preliminary Ruling in Anti-Dumping Investigation into Chinese DOP Imports
-
Sudden Turmoil in Middle East Shipping Routes: Multiple Carriers Announce Emergency Navigation and Surcharge Policies
Recommend Reading
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
Post-holiday Maleic Anhydride Prices Rise in China
-
Business Society’s Market Outlook for Petroleum Coke on August 27, 2026: Volatile
-
Business Society’s September 2, 2026 Phenol Market Outlook: Trending Stronger
-
Zimbabwe Suspends Lithium Export, Lithium Carbonate Prices Rise
-
Business Society’s Market Outlook for Ethyl Acetate on August 26, 2026: Strong Consolidation